Philip J Rosenthal
Overview
Explore the profile of Philip J Rosenthal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
494
Citations
12122
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rosenthal P, Hamer D, Bausch D, Nishi J, Fidock D
Am J Trop Med Hyg
. 2025 Mar;
PMID: 40080909
No abstract available.
2.
Ozarslan N, Mong C, Ategeka J, Li L, Buarpung S, Robinson J, et al.
Epigenetics
. 2025 Mar;
20(1):2475276.
PMID: 40051167
Fetal growth restriction (FGR) is associated with perinatal death and adverse birth outcomes, as well as long-term complications, including increased childhood morbidity, abnormal neurodevelopment, and cardio-metabolic diseases in adulthood. Placental...
3.
McClure M, Arinaitwe E, Kamya M, Rosenthal P, Nankabirwa J, Maxwell K, et al.
Res Sq
. 2025 Feb;
PMID: 39975909
Background: The gold standard measure of malaria exposure is the entomological inoculation rate (EIR), or the number of infectious bites an individual receives over a given period. Nevertheless, it is...
4.
Katairo T, Asua V, Nsengimaana B, Tukwasibwe S, Semakuba F, Wiringilimaana I, et al.
Res Sq
. 2025 Feb;
PMID: 39975885
Background: Molecular surveillance of drug-resistant is crucial for malaria control in endemic regions. Two targeted-resequencing tools, the Molecular Inversion Probe (MIP) drug resistance panel DR23K and the Multiplexed Amplicons for...
5.
Steketee R, Rosenthal P
Am J Trop Med Hyg
. 2025 Jan;
112(1):242-243.
PMID: 39879634
No abstract available.
6.
Okitwi M, Orena S, Tumwebaze P, Katairo T, Taremwa Y, Byaruhanga O, et al.
medRxiv
. 2025 Jan;
PMID: 39802777
Background: The treatment and control of malaria in Africa is challenged by drug resistance, including transporter, folate pathway, and PfK13 mutations that mediate resistance to aminoquinolines, antifolates, and artemisinins, respectively....
7.
Martinez-Vega R, Ishengoma D, Gosling R, Rosenthal P, Dondorp A, Barnes K, et al.
Lancet
. 2024 Dec;
405(10472):7-10.
PMID: 39674185
No abstract available.
8.
Gomez-Gonzalez P, Gupta A, Drought L, Patel A, Okombo J, van der Watt M, et al.
Sci Adv
. 2024 Dec;
10(49):eadq1383.
PMID: 39642214
Cyclic nucleotide-dependent phosphodiesterases (PDEs) play essential roles in regulating the malaria parasite life cycle, suggesting that they may be promising antimalarial drug targets. PDE inhibitors are used safely to treat...
9.
Luth M, Godinez-Macias K, Chen D, Okombo J, Thathy V, Cheng X, et al.
Science
. 2024 Nov;
386(6725):eadk9893.
PMID: 39607932
Surveillance of drug resistance and the discovery of novel targets-key objectives in the fight against malaria-rely on identifying resistance-conferring mutations in parasites. Current approaches, while successful, require laborious experimentation or...
10.
Okitwi M, Shoue D, Checkley L, Orena S, Ceja F, Taremwa Y, et al.
Antimicrob Agents Chemother
. 2024 Nov;
68(12):e0118324.
PMID: 39545737
Artemisinin partial resistance (ART-R) has emerged in eastern Africa, necessitating regular surveillance of susceptibility of to artemisinins. The microscopy-based ring-stage survival assay (RSA) provides a laboratory correlate of ART-R but...